GAS5 and coronary artery disorder: A study on 444 patients with CAD and on DAPT [39] focused on the interplay between long non-coding RNA growth arrest-specific 5 (GAS5) functional polymorphism rs55829688 and platelet miR-223, demonstrating that the polymorphism is involved in Clopidogrel resistance and that GAS5 overexpression reduced miR-223-3p but increased P2Y12 expression in platelets.